In cancer, the programmed death 1 (PD-1) protein binds the ligands PD-L1 and PD-L2 to attenuate T cell receptor signalling, thus allowing the tumour to evade the cytotoxic T cell response.44 Here, PDCD1 is linked to neoplasm.